ITI Pharma and Healthcare Fund - Direct Plan - Growth vs ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured
NAV, returns and costs — not a recommendation.
 ITI Pharma and Healthcare Fund - Direct Plan - Growth |  ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-Insured | |
|---|---|---|
| NAV | ₹19.7621 | ₹46.95 |
| NAV date | 2026-08-19 | 2026-08-19 |
| 1 year | +11.71% | +7.93% |
| 3 year (p.a.) | +19.91% | +22.86% |
| 5 year (p.a.) | +15.34% | +16.84% |
| Expense ratio | 0.68% | 0.87% |
| Fund size | ₹251.87 Cr | ₹6,624.58 Cr |
| Risk | Very high | Very high |
| Category | Sectoral Pharma and Healthcare | Sectoral Pharma and Healthcare |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.